Connect with us

Stock News

Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

Published

4 months ago

on


Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former executives for “misleading claims” about an Alzheimer’s clinical trial.

Related Topics:
Continue Reading

Stock News

Treasury yields trim declines after PCE inflation reading edges up from Fed’s target

Published

1 month ago

on

November 27, 2024

By

Treasury yields were trimming earlier declines after a barrage of pre-Thanksgiving economic data added to the case for gradual Fed rate cuts .

Continue Reading

Stock News

Jobless claims slide to 7-month low. Businesses not cutting many jobs.

Published

1 month ago

on

November 27, 2024

By


The number of Americans who applied for unemployment benefits in the week before the Thanksgiving holiday dipped to a seven-month low in a sign of strength for a steadily expanding U.S. economy.

Continue Reading

Stock News

More turnover at the top, but this bull still believes in the Weight Watchers parent

Published

1 month ago

on

November 27, 2024

By


D.A. Davidson reckons WW is a buy as its customers need more than a prescription.

Continue Reading

Trending